Q3 2025 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2025-10-31 · accession 0000945621-25-001004
$403.3M
Reported value
41
Positions
2025-09-30
Period end
The Brief · SECTOR GAMMA AS · Q3 2025
AI · grounded in 13F
SECTOR GAMMA AS established a new position in PFE valued at $31.9M. The fund also initiated new stakes in MDT for $28.9M and MRK for $27.1M. Additional new positions include BMY at $26.2M and BDX at $20.4M. The fund ended the period with 41 positions and total AUM of $403.3M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 717081103 | PFE | PFIZER INC | $31.9M | 7.91% | 1,252,086 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $28.9M | 7.17% | 303,441 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $27.1M | 6.71% | 322,500 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $26.2M | 6.50% | 581,267 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $20.4M | 5.05% | 108,829 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $17.7M | 4.40% | 270,963 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $17.4M | 4.31% | 205,114 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $17.3M | 4.30% | 61,456 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $16.3M | 4.05% | 147,239 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $11.8M | 2.92% | 156,202 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $11.2M | 2.77% | 113,478 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $10.6M | 2.62% | 75,475 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $9.5M | 2.36% | 175,852 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $9.3M | 2.32% | 59,536 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $8.9M | 2.22% | 18,444 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $8.7M | 2.15% | 381,551 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $8.4M | 2.07% | 111,390 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $8.2M | 2.02% | 250,909 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $7.6M | 1.89% | 213,210 | Common | SOLE |
| 504922105 | LH | LABCORP HOLDINGS INC | $7.5M | 1.85% | 25,970 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $7.2M | 1.80% | 118,112 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $6.6M | 1.64% | 668,851 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $6.4M | 1.59% | 22,827 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $6.2M | 1.54% | 23,942 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $6.2M | 1.53% | 307,271 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $6.0M | 1.48% | 477,104 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $5.8M | 1.44% | 543,711 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $5.7M | 1.41% | 72,980 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $5.2M | 1.28% | 76,821 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $4.8M | 1.20% | 24,327 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $4.6M | 1.15% | 10,883 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $4.4M | 1.08% | 24,967 | Common | SOLE |
| 83444M101 | SOLV | SOLVENTUM CORP | $4.3M | 1.07% | 59,259 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $3.9M | 0.96% | 438,415 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $3.3M | 0.82% | 64,403 | Common | SOLE |
| 875372203 | TNDM | TANDEM DIABETES CARE INC | $3.3M | 0.81% | 269,542 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $3.2M | 0.80% | 210,814 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC FORMERLY | $3.1M | 0.77% | 9,603 | Common | SOLE |
| 15687V109 | CERT | CERTARA INC | $2.8M | 0.70% | 230,565 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $2.7M | 0.68% | 27,732 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $2.6M | 0.65% | 32,009 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.